22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA’s Tobacco Products Scientific Advisory Committee
Williamsville, NY, Dec. 23, 2019 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is […]